华谊兄弟(300027.SZ):电影《志愿军:存亡之战》票房收入约为8.62亿元
格隆汇10月8日丨华谊兄弟(300027.SZ)公布,子公司参与投资的影片《志愿军:存亡之战》(以下简称“该影片”)于2024年9月30日起在中国大陆地区公映。根据国家电影专资办数据显示,截至2024年10月7日24时,该影片在中国大陆地区上映8天,累计票房收入(即影片的累计总票房)约为人民币8.62亿元(最终结算数据可能略有误差),超过公司最近一个会计年度经审计的合并财务报表营业收入的50%。
截至2024年10月7日,公司来源于该影片的营业收入区间约为人民币90万元至人民币117万元(最终结算数据可能存在误差)。目前,该影片还在上映中,该影片在中国大陆地区的票房收入以中国大陆地区各电影院线正式确认的结算单为准;同时,该影片在中国大陆地区的非院线发行收入及海外地区的发行收入等尚未最终结算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.